You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STI571 (Gleevec)

Showing 1 - 25 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Gastrointestinal Stromal Tumor Trial in Philadelphia (Conventional Surgery, Imatinib Mesylate)

Completed
Has Results
  • Gastrointestinal Stromal Tumor
  • Conventional Surgery
  • Imatinib Mesylate
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 22, 2020

Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

Active, not recruiting
  • Liver Fibrosis
  • Imatinib 200mg
  • Placebo
  • Tehran, Iran, Islamic Republic of
    Research Institute of Gastroenterology & Liver Diseases
Jan 24, 2022

Systemic Sclerosis, Scleroderma Trial in Worldwide (STI571)

Completed
Has Results
  • Systemic Sclerosis, Scleroderma
  • Chicago, Illinois
  • +6 more
Jul 5, 2021

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +15 more
Jun 3, 2021

Uterine Cancer Trial in Houston (Imatinib Mesylate, Paclitaxel)

Terminated
Has Results
  • Uterine Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 26, 2020

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed
Has Results
  • Philadelphia Chromosome Positive CML
  • imatinib mesylate
  • Chicago, Illinois
  • +9 more
Jun 3, 2021

Melanoma, Advanced Melanoma Trial in Philadelphia (Gleevec + Temozolomide)

Terminated
  • Melanoma
  • Advanced Melanoma
  • Gleevec + Temozolomide
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Apr 6, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,

Completed
Has Results
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2020

Sclerotic GVHD, Imatinib Mesylate Trial run by the NCI (Gleevec, STI571(Imatinib Mesylate))

Completed
Has Results
  • Sclerotic Graft Versus Host Disease
  • Imatinib Mesylate
  • Gleevec, STI571(Imatinib Mesylate)
  • Bethesda, Maryland
    National Cancer Institute (NCI), 9000 Rockville Pike
Mar 27, 2020

Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

Completed
Has Results
  • Philadelphia Positive Chronic Myeloid Leukemia
  • +2 more
  • STI571 400 mg
  • STI571 600 mg
  • Boston, Massachusetts
  • +11 more
Jul 1, 2021

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in Worldwide (STI571)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Los Angeles, California
  • +27 more
Jul 1, 2021

Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
Feb 14, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,

Completed
Has Results
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +9 more
  • Denver, Colorado
  • +2 more
Jan 17, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Colonic Tumors Trial in Amersfoort, Utrecht (Imatinib)

Terminated
  • Colonic Neoplasms
  • Amersfoort, Utrecht, Netherlands
  • +2 more
Oct 9, 2019

Leukemia Trial in China (Imatinib, Nilotinib)

Completed
Has Results
  • Leukemia
  • Guangzhou, Guangdong, China
  • +11 more
Jul 11, 2019

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting
  • GIST and CML
  • imatinib mesylate
  • Los Angeles, California
  • +28 more
Apr 25, 2022

Pulmonary Veno Occlusive Disease Trial in Boston (Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Pulmonary Veno Occlusive Disease
  • Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
  • Boston, Massachusetts
    Boston Childrens Hospital
Jun 6, 2019

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020